• Pharma
  • February 12, 2025
  • 536 views
Pharma companies turn to AI to speed up drug development, but hit hurdles

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…